TZ2

Dual-incretin research candidate for metabolic study designs.

Dual-incretin research candidate for metabolic study designs
Purity ≥ 99.8% (HPLC)
Lot-specific COA ships with every order

Secure checkout · Free shipping over $60 · Damage protected

Order within

3rd-party tested

Free ship over $60

Damage protected

The why

TZ2 is an investigational dual receptor incretin analog supplied for in-vitro and preclinical metabolic work, including glucose handling and satiety signaling models.

Key ingredients

TZ2 10 mg / 20 mg / 40 mg
Sterile lyophilized powder

Certificate of Analysis

Every lot, tested and documented.

Independent third-party analysis on every TZ2 lot by Vanguard Laboratory (A2LA accredited). Purity, quantity, identity, heavy metals, endotoxins and bioburden. The results below are pulled straight from the signed report.

Verified by Vanguard HPLC-UV/VIS ICP-MS USA-shipped

Vanguard Laboratory · Level 3 verified

Veyron TZ2

Open signed COA

Lot number

TZ2.10.A

Laboratory ID

V260617-22025

Date reported

6/25/2026

Report number

V260617-22 025

Chromatographic purity

>99.80%

Quantity per vial

11.35 mg

Endotoxins (LAL)

Pass - <5.00 EU/mg

Bioburden (USP 61)

Pass - No Growth Detected

Heavy metals (ICP-MS)

Not detected

Signed by

Dustin Newman, Laboratory Director

Values above are transcribed from the Vanguard Laboratory report for lot TZ2.10.A. Heavy metals reported as ND (not detected) for arsenic, cadmium, lead and mercury. Open the signed PDF for chromatograms and the full analyte table.

What we test

Purity + identity
>99.80%
HPLC-UV/VIS chromatographic purity against a reference standard.
Quantity
11.35 mg
Confirms the vial holds at least what the label says.
Heavy metals
Not detected
ICP-MS screen for arsenic, cadmium, lead and mercury.
Endotoxins + bioburden
Pass - <5.00 EU/mg
LAL endotoxin assay and USP 61 microbial count screening.